SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss
16 juil. 2024 06h03 HE
|
SciSparc Ltd
TEL AVIV, Israel, July 16, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...
Ladybug's Acquisition of E-Commerce Platform Set to Boost Annual Revenue by $2.5 Million, Aligning with Revenue Target for 2024
03 avr. 2024 08h05 HE
|
LadyBug Resource Group, Inc.
Ladybug's Acquisition of E-Commerce Platform Set to Boost Annual Revenue by $2.5 Million, Aligning with Revenue Target for 2024.
Ladybug Resource Group Continues to Strive Toward $25 Million 2024 Revenue Goal.
27 mars 2024 08h00 HE
|
LadyBug Resource Group, Inc.
Ladybug Resource Group Continues to Strive Toward $25 Million 2024 Revenue Goal.
Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials
20 févr. 2024 08h38 HE
|
Fractyl Health, Inc.
Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials
US-Based Yes You Can! Appoints New Executive Team to Lead Global Market Expansion
04 nov. 2021 16h00 HE
|
Yes You Can!
MIAMI, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Alejandro Chaban, CEO & Founder of health and wellness social networking company Yes You Can! (YYC!), plans to bring awareness of his easy-to-follow...
Obalon Announces Fourth Quarter and Full Year 2020 Financial Results
12 mars 2021 19h12 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Third Quarter 2020 Financial Results
06 nov. 2020 16h45 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Second Quarter 2020 Financial Results
30 juil. 2020 06h38 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces First Quarter 2020 Financial Results and Business Update
19 juin 2020 06h15 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment
11 mai 2020 08h30 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and...